Fatal pulmonary hemorrhage after taking anticoagulation medication

We describe a 64-year-old man with extensive diffuse acute lung hemorrhage, presumably as a result of anticoagulation therapy. We evaluated reports in the literature concerning acute exacerbation (acute lung injury of unknown cause) in UIP and other forms of fibrotic interstitial pneumonias. We also...

Full description

Bibliographic Details
Main Author: Samuel P. Hammar
Format: Article
Language:English
Published: Elsevier 2015-01-01
Series:Respiratory Medicine Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2213007115000441
_version_ 1831707095134633984
author Samuel P. Hammar
author_facet Samuel P. Hammar
author_sort Samuel P. Hammar
collection DOAJ
description We describe a 64-year-old man with extensive diffuse acute lung hemorrhage, presumably as a result of anticoagulation therapy. We evaluated reports in the literature concerning acute exacerbation (acute lung injury of unknown cause) in UIP and other forms of fibrotic interstitial pneumonias. We also evaluated autopsy tissue in this case in order to determine the cause of death in this 64-year-old man, who was initially thought to have an asbestos-related disease. Based on the autopsy findings, this man died as a result of anticoagulation therapy; specifically, the use of Xarelto® (rivaroxaban).
first_indexed 2024-12-20T18:11:39Z
format Article
id doaj.art-0a0200dfbef24c6688e3ece4cc87fa4a
institution Directory Open Access Journal
issn 2213-0071
language English
last_indexed 2024-12-20T18:11:39Z
publishDate 2015-01-01
publisher Elsevier
record_format Article
series Respiratory Medicine Case Reports
spelling doaj.art-0a0200dfbef24c6688e3ece4cc87fa4a2022-12-21T19:30:27ZengElsevierRespiratory Medicine Case Reports2213-00712015-01-0115C667010.1016/j.rmcr.2015.05.010Fatal pulmonary hemorrhage after taking anticoagulation medicationSamuel P. HammarWe describe a 64-year-old man with extensive diffuse acute lung hemorrhage, presumably as a result of anticoagulation therapy. We evaluated reports in the literature concerning acute exacerbation (acute lung injury of unknown cause) in UIP and other forms of fibrotic interstitial pneumonias. We also evaluated autopsy tissue in this case in order to determine the cause of death in this 64-year-old man, who was initially thought to have an asbestos-related disease. Based on the autopsy findings, this man died as a result of anticoagulation therapy; specifically, the use of Xarelto® (rivaroxaban).http://www.sciencedirect.com/science/article/pii/S2213007115000441Acute lung hemorrhageAnticoagulation therapyXarelto®Rivaroxaban
spellingShingle Samuel P. Hammar
Fatal pulmonary hemorrhage after taking anticoagulation medication
Respiratory Medicine Case Reports
Acute lung hemorrhage
Anticoagulation therapy
Xarelto®
Rivaroxaban
title Fatal pulmonary hemorrhage after taking anticoagulation medication
title_full Fatal pulmonary hemorrhage after taking anticoagulation medication
title_fullStr Fatal pulmonary hemorrhage after taking anticoagulation medication
title_full_unstemmed Fatal pulmonary hemorrhage after taking anticoagulation medication
title_short Fatal pulmonary hemorrhage after taking anticoagulation medication
title_sort fatal pulmonary hemorrhage after taking anticoagulation medication
topic Acute lung hemorrhage
Anticoagulation therapy
Xarelto®
Rivaroxaban
url http://www.sciencedirect.com/science/article/pii/S2213007115000441
work_keys_str_mv AT samuelphammar fatalpulmonaryhemorrhageaftertakinganticoagulationmedication